Loading

Welcome to ProBioGen

We Support Your Biopharmaceutical Visions.

LATEST NEWS

ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology

UPCOMING EVENTS

26.02.2012 - 28.02.2012

Vancouver, BC, Canada

19.03.2012 - 21.03.2012

Amsterdam, The Netherlands